Your browser doesn't support javascript.
loading
Interactions of anti-COVID-19 drug candidates with hepatic transporters may cause liver toxicity and affect pharmacokinetics.
Ambrus, Csilla; Bakos, Éva; Sarkadi, Balázs; Özvegy-Laczka, Csilla; Telbisz, Ágnes.
Afiliação
  • Ambrus C; SOLVO Biotechnology, Irinyi József street 4-20, 1117, Budapest, Hungary.
  • Bakos É; Doctoral School of Molecular Medicine, Semmelweis University, Tuzoltó u. 37-47, 1094, Budapest, Hungary.
  • Sarkadi B; Institute of Enzymology, ELKH Research Centre for Natural Sciences, Magyar Tudósok krt. 2, 1117, Budapest, Hungary.
  • Özvegy-Laczka C; Institute of Enzymology, ELKH Research Centre for Natural Sciences, Magyar Tudósok krt. 2, 1117, Budapest, Hungary.
  • Telbisz Á; Department of Biophysics and Radiation Biology, Semmelweis University, Tuzoltó u. 37-47, 1094, Budapest, Hungary.
Sci Rep ; 11(1): 17810, 2021 09 08.
Article em En | MEDLINE | ID: mdl-34497279
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article